- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
2011 ASH-AMFDP Award Recipient to Study Treatment for Leukemia/Lymphoma
The annual award given to underrepresented minority scholars is given this year to a woman who will be studying treatment options for T-cell leukemia/lymphoma:
"Adrienne Phillips, MD, MPH, has been selected to receive the ASH-AMFDP Award to conduct research on HLTV-1 adult T-cell leukemia/lymphoma. The award, designed to help increase the number of underrepresented minority scholars in the field of hematology, is the result of a partnership between the American Society of Hematology (ASH) and the Harold Amos Medical Faculty Development Program (AMFDP) of the Robert Wood Johnson Foundation. It provides four years of support, including an annual stipend of up to $75,000 and an annual grant of $30,000 to support research activities.
"I was thrilled and honored to be the recipient of the ASH-AMFDP award for 2011," said Dr. Phillips. "This award represents an outstanding career development opportunity for which I am tremendously grateful. The support provided by ASH and AMFDP will give me protected time, funding, and career counseling that will advance my research and support my development as an academic hematologist." "